Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, Wash., May 15, 2014 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency...
-
VANCOUVER, Wash., May 14, 2014 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency...
-
SANTE FE, N.M., March 28, 2006 (PRIMEZONE) -- CytoDyn, Inc. (OTCBB:CYDY), best known for Cytolin(r), a targeted immune therapy for treating HIV/AIDS, has announced plans to develop a nonsynthetic...
-
SANTA FE, N.M., March 27, 2006 (PRIMEZONE) -- CytoDyn, Inc. (OTCBB:CYDY) has applied for the trademark Formaxycin(tm) (fer-MAX-uh-sin) to brand its new cancer drug. Like several approved cancer drugs,...
-
ALBUQUERQUE, N.M., March 20, 2006 (PRIMEZONE) -- A recent meeting of the New Mexico Biotechnology & Biomedical Association featured a talk by Allen D. Allen, CEO of CytoDyn, Inc. (OTCBB:CYDY)....